Skip to main navigation

About Us
Our Products
Investor Relations
News
Cumberland Emerging Technologies
Blog

About Us
Our Products
Investor Relations
News
Cumberland Emerging Technologies
Blog

Press Releases

Year

Cumberland Pharmaceuticals Announces ASSIST-SSc Trial Top-Line Results

Oct 23, 2026

SSc Study Topline Results - 26 Oct 2026

CUMBERLAND PHARMACEUTICALS PROVIDES UPDATED WEBCAST REGISTRATION LINK FOR IFETROBAN DMD PROGRAM CALL

Oct 23, 2026

PDF Version

CUMBERLAND PHARMACEUTICALS ANNOUNCES NATIONAL CALL TO PRESENT AN UPDATE ON ITS IFETROBAN DMD PROGRAM

Oct 19, 2026

PDF Version

CUMBERLAND PHARMACEUTICALS OUTLINES STRATEGIC TRANSFORMATION AND REAFFIRMS COMMITMENT TO NASHVILLE’S LIFE SCIENCES COMMUNITY

Sep 14, 2026

PDF Version

CUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS

Aug 04, 2026

PDF Version

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS

Jul 28, 2026

PDF Version

CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE

Jul 13, 2026

PDF Version

/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./

Jul 13, 2026

PDF Version

Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex

Jul 01, 2026

PDF Version

Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference

Jun 26, 2026

PDF Version

Presentation

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 24

© 2026 Cumberland Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy

Accessibility Statement

Terms of Use